Back
Vanguard S&P Mid-Cap 400 Value Index Fund ETF Vs. Novartis AG Industry Stock Comparison
Buy
63
IVOV
Vanguard S&P Mid-Cap 400 Value Index Fund ETF
Last Price:
$93.72
Seasonality Move:
0.46%
Buy
71
NVSEF
Novartis AG
Last Price:
$119.18
Seasonality Move:
3.12%
Buy
63
Vanguard S&P Mid-Cap 400 Value Index Fund ETF (IVOV)
is a Buy
Is Vanguard S&P Mid-Cap 400 Value Index Fund ETF a Buy, Sell or Hold?
-
The current Vanguard S&P Mid-Cap 400 Value Index Fund ETF [IVOV] share price is $93.76. The Score for IVOV is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
-
IVOV is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
71
Novartis AG (NVSEF)
is a Buy
Is Novartis AG a Buy, Sell or Hold?
-
The current Novartis AG [NVSEF] share price is $119.18. The Score for NVSEF is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
-
NVSEF is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
IVOV Stock Price Chart
What is Vanguard S&P Mid-Cap 400 Value Index Fund ETF's stock price today?
-
The Vanguard S&P Mid-Cap 400 Value Index Fund ETF share price today is $93.76Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IVOV is experiencing slight buying pressure.
NVSEF Stock Price Chart
What is Novartis AG's stock price today?
-
The Novartis AG share price today is $119.18Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVSEF is experiencing slight buying pressure.
IVOV Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.75 | Buy |
Relative Strength Index (14 RSI): | 56.34 | Buy |
Chaikin Money Flow: | 1268 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (91.99 - 94.15) | Buy |
Bollinger Bands (100): | (88.1 - 97.16) | Buy |
NVSEF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.53 | Buy |
Relative Strength Index (14 RSI): | 71.36 | Buy |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (108.21 - 116.93) | Buy |
Bollinger Bands (100): | (104.36 - 114.26) | Buy |
IVOV Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 93.51 | Buy |
20-day SMA: | 92.84 | Buy |
50-day SMA: | 89.82 | Buy |
200-day SMA: | 95.02 | Sell |
8-day EMA: | 93.41 | Buy |
20-day EMA: | 92.78 | Buy |
50-day EMA: | 91.93 | Buy |
200-day EMA: | 92.75 | Buy |
NVSEF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 117.81 | Buy |
20-day SMA: | 113.77 | Buy |
50-day SMA: | 110.28 | Buy |
200-day SMA: | 107.7 | Buy |
8-day EMA: | 117.59 | Buy |
20-day EMA: | 114.87 | Buy |
50-day EMA: | 111.9 | Buy |
200-day EMA: | 107.49 | Buy |
Vanguard S&P Mid-Cap 400 Value Index Fund ETF Earnings Growth & IVOV Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Novartis AG Earnings Growth & NVSEF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Vanguard S&P Mid-Cap 400 Value Index Fund ETF Technical Analysis
Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novartis AG Technical Analysis
Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |